Prognostic Role of LA Strain in Acute Myocardial Infarction

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages Any age
• All sexes
• No healthy volunteers
• Child, Adult, Older adult

Study population: This is a single-center retrospective observational study in which we consecutively selected patients diagnosed with acute myocardial infarction from September 2019 to March 2024 at the Affiliated Hospital of Xuzhou Medical University. Dedicated cardiovascular imaging software CVI42 (cvi42® version 5.13.5, Circle Cardiovascular Imaging, Canada) was used for image analysis. LA strain was obtained by cardiac MRI feature tracking. Patient prognosis was obtained through chart notes and telephone follow-up. Major events included atrial fibrillation, ischemic stroke, and all-cause mortality.

Trial locations and contacts

1 site in 1 country.

About this study

Official title: Cardiac MRI Left Atrial Strain Associated With Ischemic Stroke in Patients With Acute Myocardial Infarction

Conditions

Atrial Fibrillation, Myocardial Infarction, Acute, Stroke Ischemic, Mortality

Being tested

Cardiac MRI

Keywords

cardiac magnetic resonance, myocardial infarction, atrial fibrillation, ischemic stroke

Medical subject headings

Atrial Fibrillation, Myocardial Infarction, Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Cardiac MRIOther

  All selected patients completed a cardiac magnetic resonance examination without other interventions.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Primary endpoint events included all-cause death, ischemic stroke, and atrial fibrillation

   Measured: All patients were followed until March 31, 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted10 May 2024
2. Study start2 Sep 2019
3. Primary completion31 Mar 2024
4. Study completion31 Mar 2024

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Atrial FibrillationStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.